Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Pharmacokinetic behavior of orally administrated formulations involves dissolution and absorption in the gastrointestinal tract (GIT), which is required for the systemic effects of a drug. The dissolution and subsequent penetration through the intestinal epithelia is a vital step toward in vivo bioavailability. A lot of effort has been devoted to the study of physiological characteristics of GIT by means of in vitro dissolution methods or in vitro permeation methods. Moreover, drug dissolution/permeation synchronous evaluation technology could be employed to predict the process of drug dissolution and absorption by the combination of dissolution apparatus and permeation apparatus. Better prediction tools are priority in the critical path initiative of US Food and Drug Administration. The studies and applications of the drug dissolution/permeation synchronous evaluation technology are attracting more and more attention each year. However, there is no systematic review on the theoretical basis and the recent development. Therefore, in this review, we will give an overview on the physiological basis and theoretical basis of the drug dissolution/permeation synchronous evaluation technology, as well as their recent advances of this kind of equipments at home and abroad. Moreover, we have also compared their advantages and disadvantages, and the applicable scopes. With hope that the critical path study will promote the development of innovative drug research and development, and improve the druggability.

Download full-text PDF

Source

Publication Analysis

Top Keywords

drug dissolution/permeation
16
dissolution/permeation synchronous
16
synchronous evaluation
16
evaluation technology
12
drug
8
physiological characteristics
8
dissolution absorption
8
drug dissolution
8
critical path
8
theoretical basis
8

Similar Publications

Prodrugs with enzymatic activation requirements, such as the weakly basic biopharmaceutical classification system (BCS) class IV compound abiraterone acetate (ABA), face considerable bioequivalence (BE) risks owing to their pH-dependent solubility, food effects, and variable intestinal hydrolysis. This study established clinically relevant dissolution specifications for ABA using biorelevant dissolution and physiologically based biopharmaceutics modelling (PBBM). Two dissolution methods, two-stage (gastrointestinal transfer simulation) and single-phase (biorelevant media), were evaluated under fasted and fed conditions.

View Article and Find Full Text PDF

Indomethacin is a poorly soluble weak acid and a widely used model drug in enabling formulations. When using microdialysis for sampling of indomethacin from a buffer containing calcium, we observed the formation of nanoparticles of a poorly water-soluble indomethacin calcium salt. The nanoparticles were not detected during solubility experiments where filtration had been used to separate the solid phase because the nanoparticles were unusually small in size, less than 2 nm in diameter as determined by DLS.

View Article and Find Full Text PDF

Stiripentol (STP), an antiepileptic drug, is administered orally in the form of capsule and dry suspension. However, it is extremely unstable in acidic environment. Hence, to find the feasibility of alternate route of administration and to enhance the bioavailability of drug, STP loaded intranasal in-situ nanolipoidal gel formulation was formulated.

View Article and Find Full Text PDF

Introduction: Canagliflozin hemihydrate (CANA), an antidiabetic drug that functions as a sodiumglucose co-transporter 2 (SGLT2) inhibitor, is classified under the Biopharmaceutical Classification System (BCS) as a Class IV drug, characterized by low solubility and low permeability. This study aimed to enhance the solubility, dissolution, and permeability of CANA by preparing its inclusion complexes with α- cyclodextrin (α-CD) and β-cyclodextrin (β-CD), followed by characterization of their crystalline and biopharmaceutical properties.

Methods: The solubility of CANA in aqueous medium and phase solubility with α and β-cyclodextrin were conducted.

View Article and Find Full Text PDF

Lipid-based nanocarrier systems have multiple advantages, including biocompatibility, biodegradability and drug loading capacity. Combining these findings with the concept of dissolving microneedles (MNs) would aid in the efficient delivery of peptides and improve therapeutic outcomes. Thus, MN-mediated transdermal delivery was explored for the delivery of salmon calcitonin (sCT).

View Article and Find Full Text PDF